Genosyl: payments to doctors
Payments that named Genosyl as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $75K
- Providers
- 25
- Transactions
- 251
- Average per transaction
- $300
The per-transaction average — $300 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 25 providers the average total is $3,014, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vero Biotech Inc. | $55,332 | 73.4% |
| Vero Biotech LLC | $20,030 | 26.6% |